Despite the usefulness of N-terminal propeptide of type III procollagen (PIIINP) in detecting enhanced collagen turnover in patients with congestive heart failure, the value added by PIIINP to the use of clinical variables and echocardiography in relation to directly measured left ventricular (LV) end-diastolic pressure (EDP) and the outcome of acute coronary syndrome (ACS) has not been clearly defined. = 0.027).PIIINP is a highly effective means to evaluate LVEDP in patients with ACS. The PIIINP is also correlated with cardiac mortality and revascularization, providing an additional means of evaluating and managing patients with ACS
Abstract The development and progression of heart failure accelerate obesity, disorders of carbohydr...
Background—Biochemical markers are useful for prediction of cardiac events in patients with non–ST-s...
Risk stratification in acute coronary syndromes (ACS) has been previously based on the severity of a...
Despite the usefulness of N-terminal propeptide of type III procollagen (PIIINP) in detecting enhanc...
Aim. To study changes in the level of fibrotic scarring marker — the N-terminal propeptide type III ...
The levels of aminoterminal propeptide of type III procollagen (PIIINP) can be used as an index of c...
Background: In chronic heart failure (CHF), changes in the extracellular space contribute to cardiac...
<p>Concentrations of N-terminal propeptide of type III procollagen in three groups of patients with ...
BACKGROUND: The serum concentrations of two procollagen-derived peptides, procollagen type III amino...
Objectives: The association of cardiac fibrosis and coronary artery disease (CAD) in patients withou...
Aim. To study the dynamics of procollagen type I carboxy-terminal propeptide (PICP) with an assessme...
Background: Cardiac extra-cellular matrix (ECM) fibrosis plays an important role in the pathophysiol...
Aims Procollagen type I C-terminal propeptide (PICP) and procollagen type III N-terminal propeptide ...
Background: The amino-terminal propepticles of type I and III procollagens (PINP and PIIINP) are mar...
OBJECTIVE: To study the association of circulating markers of fibrosis: procollagen type III amino-t...
Abstract The development and progression of heart failure accelerate obesity, disorders of carbohydr...
Background—Biochemical markers are useful for prediction of cardiac events in patients with non–ST-s...
Risk stratification in acute coronary syndromes (ACS) has been previously based on the severity of a...
Despite the usefulness of N-terminal propeptide of type III procollagen (PIIINP) in detecting enhanc...
Aim. To study changes in the level of fibrotic scarring marker — the N-terminal propeptide type III ...
The levels of aminoterminal propeptide of type III procollagen (PIIINP) can be used as an index of c...
Background: In chronic heart failure (CHF), changes in the extracellular space contribute to cardiac...
<p>Concentrations of N-terminal propeptide of type III procollagen in three groups of patients with ...
BACKGROUND: The serum concentrations of two procollagen-derived peptides, procollagen type III amino...
Objectives: The association of cardiac fibrosis and coronary artery disease (CAD) in patients withou...
Aim. To study the dynamics of procollagen type I carboxy-terminal propeptide (PICP) with an assessme...
Background: Cardiac extra-cellular matrix (ECM) fibrosis plays an important role in the pathophysiol...
Aims Procollagen type I C-terminal propeptide (PICP) and procollagen type III N-terminal propeptide ...
Background: The amino-terminal propepticles of type I and III procollagens (PINP and PIIINP) are mar...
OBJECTIVE: To study the association of circulating markers of fibrosis: procollagen type III amino-t...
Abstract The development and progression of heart failure accelerate obesity, disorders of carbohydr...
Background—Biochemical markers are useful for prediction of cardiac events in patients with non–ST-s...
Risk stratification in acute coronary syndromes (ACS) has been previously based on the severity of a...